| scholarly article | Q13442814 |
| P2093 | author name string | Damiano Rondelli | |
| Victor R Gordeuk | |||
| Matthew Koshy | |||
| Robert E Molokie | |||
| Nadim Mahmud | |||
| Santosh L Saraf | |||
| David Peace | |||
| Irum Khan | |||
| John G Quigley | |||
| Pritesh R Patel | |||
| Shivi Jain | |||
| Annie L Oh | |||
| Karen Sweiss | |||
| Sally Campbell-Lee | |||
| Michel Gowhari | |||
| P2860 | cites work | Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel | Q33558770 |
| National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report | Q34474243 | ||
| High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation | Q35073502 | ||
| Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype | Q36423553 | ||
| HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease | Q36425417 | ||
| Long-term outcome and evaluation of organ function in pediatric patients undergoing haploidentical and matched related hematopoietic cell transplantation for sickle cell disease. | Q36461789 | ||
| HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide | Q37078261 | ||
| Granulocyte colony-stimulating factor (G-CSF) administration in individuals with sickle cell disease: time for a moratorium? | Q37354296 | ||
| 1994 Consensus Conference on Acute GVHD Grading | Q39513397 | ||
| Gene Therapy in a Patient with Sickle Cell Disease | Q40313066 | ||
| Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation | Q40411281 | ||
| A trial of unrelated donor marrow transplantation for children with severe sickle cell disease | Q40582651 | ||
| Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathies. | Q41010661 | ||
| Current attitudes of parents and patients toward hematopoietic stem cell transplantation for sickle cell anemia | Q41159892 | ||
| HLA-Haploidentical Stem Cell Transplant with Pre-Transplant Immunosuppression for Patients with Sickle Cell Disease | Q41931914 | ||
| Availability of related donors for bone marrow transplantation in sickle cell anemia | Q44545670 | ||
| Bone marrow transplant options and preferences in a sickle cell anemia cohort on chronic transfusions | Q45150943 | ||
| Stem cell transplant for children with sickle cell anemia: parent and patient interest. | Q46040080 | ||
| Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell-Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide. | Q47573519 | ||
| Nonmyeloablative Stem Cell Transplantation with Alemtuzumab/Low-Dose Irradiation to Cure and Improve the Quality of Life of Adults with Sickle Cell Disease | Q47970708 | ||
| Are the risks of treatment to cure a child with severe sickle cell disease too high? | Q49693306 | ||
| HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry | Q50109403 | ||
| Plerixafor enables the safe, rapid, efficient mobilization of haematopoietic stem cells in sickle cell disease patients after exchange transfusion | Q50145999 | ||
| Bone marrow transplantation for sickle cell disease. A study of parents' decisions | Q68016851 | ||
| Allogeneic stem cell transplantation for sickle cell disease. A study of patients' decisions | Q74633633 | ||
| A survey on patient perception of reduced-intensity transplantation in adults with sickle cell disease | Q79862625 | ||
| Alternative donor transplantation for aplastic anemia | Q83217260 | ||
| Cyclophosphamide improves engraftment in patients with SCD and severe organ damage who undergo haploidentical PBSCT | Q89776833 | ||
| P921 | main subject | sickle-cell disease | Q185034 |
| P577 | publication date | 2018-04-12 | |
| P1433 | published in | Biology of Blood and Marrow Transplantation | Q15754328 |
| P1476 | title | Haploidentical Peripheral Blood Stem Cell Transplantation Demonstrates Stable Engraftment in Adults with Sickle Cell Disease. |
| Q90460184 | Allogeneic Hematopoietic Stem Cell Transplantation for Adults with Sickle Cell Disease |
| Q64290977 | Bone marrow transplantation for adolescents and young adults with sickle cell disease: Results of a prospective multicenter pilot study |
| Q92410598 | Effect of increased dose of total body irradiation on graft failure associated with HLA-haploidentical transplantation in patients with severe haemoglobinopathies: a prospective clinical trial |
| Q89575141 | GPRASP proteins are critical negative regulators of hematopoietic stem cell transplantation |
| Q92023521 | Haploidentical CD3 or α/β T-cell depleted HSCT in advanced stage sickle cell disease |
| Q90583023 | Haploidentical bone marrow transplant with posttransplant cyclophosphamide for sickle cell disease: An update |
| Q60923179 | NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE |
Search more.